SBNO1-AS1

Across TCGA pan-cancer cohorts, SBNO1-AS1 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated SBNO1-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher SBNO1-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SBNO1-AS1 expression acts as an unfavorable survival marker, although some lineages such as UVM and PAAD show a favorable association.

KIRC, UVM, and PAAD are the cancer types where SBNO1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.532	0.706	<.001	125	view →
UVM	DFS	Median	All	0.767	0.395	<.001	60	view →
PAAD	OS	Median	All	0.527	0.250	<.001	53	view →
UCEC	DFS	Median	All	0.763	0.509	.001	44	view →
LUAD	DFS	Median	IV	0.406	0.817	.007	24	view →
ACC	OS	Tertile	All	0.345	0.812	.002	23	view →
COAD	OS	Median	IV	0.484	0.780	.001	21	view →
UCS	OS	Median	II,III,IV	0.752	0.464	.017	20	view →
LUSC	OS	Median	All	0.799	0.723	.012	18	view →
PRAD	DFS	Median	All	0.678	0.860	<.001	18	view →
LIHC	DFS	Median	All	0.380	0.486	.004	14	view →
THCA	OS	Median	IV	0.545	0.924	.005	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

SBNO1-AS1–KIRC (DFS)

Open the KIRC breakdown →